FY2025 EPS Estimates for electroCore Cut by HC Wainwright

electroCore, Inc. (NASDAQ:ECOR) – Equities researchers at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for electroCore in a report issued on Thursday, November 6th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($1.63) for the year, down from their previous forecast of ($1.53). The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s Q4 2025 earnings at ($0.31) EPS and FY2026 earnings at $0.32 EPS.

electroCore (NASDAQ:ECOR) last issued its earnings results on Wednesday, November 5th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The business had revenue of $8.69 million during the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. electroCore has set its FY 2025 guidance at EPS.

Several other equities research analysts have also recently issued reports on ECOR. Weiss Ratings restated a “sell (e+)” rating on shares of electroCore in a report on Wednesday, October 8th. Wall Street Zen raised electroCore from a “sell” rating to a “hold” rating in a report on Saturday. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, electroCore presently has an average rating of “Hold” and an average target price of $25.50.

electroCore Stock Up 1.3%

Shares of ECOR stock opened at $6.30 on Monday. The company has a 50 day moving average price of $5.07 and a 200-day moving average price of $5.58. electroCore has a 52 week low of $4.16 and a 52 week high of $19.49. The firm has a market capitalization of $50.40 million, a PE ratio of -3.68 and a beta of 0.30.

Hedge Funds Weigh In On electroCore

Several institutional investors and hedge funds have recently bought and sold shares of ECOR. AWM Investment Company Inc. grew its holdings in electroCore by 95.0% during the first quarter. AWM Investment Company Inc. now owns 318,106 shares of the company’s stock valued at $2,128,000 after purchasing an additional 154,973 shares during the period. NewEdge Advisors LLC lifted its position in shares of electroCore by 857.9% during the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after buying an additional 145,047 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of electroCore by 65.7% during the 2nd quarter. International Assets Investment Management LLC now owns 77,020 shares of the company’s stock valued at $407,000 after acquiring an additional 30,550 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in electroCore in the 1st quarter worth approximately $153,000. Finally, Jane Street Group LLC increased its holdings in electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after acquiring an additional 19,599 shares in the last quarter. 26.74% of the stock is currently owned by hedge funds and other institutional investors.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.